Find and Pitch Jounalists, Get Your Story Covered

Tags: startups ai evs layoffs ransomware

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Novo Nordisk Adds to Manufacturing Capacity, Pumping Billions Into New Rare Disease Site - 10 days ago Eli Lilly Plans $4.5B Medicine Foundry to Foster Innovations in Drug Manufacturing - 3 months ago AstraZeneca Plans $1.5B Manufacturing Site for Global Production of ADC Cancer Drugs - 7 months ago
2	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	3 closely watched drugs that failed in the clinic - 10 days ago Trump’s tariffs could put more pressure on the U.S. to produce generic drugs. Are we ready? - 20 days ago Pharma takes aim at a wily foe — the Epstein-Barr virus - about 2 months ago 2024 PharmaVoice 100s: Rare Disease Warriors - about 2 months ago 2024 PharmaVoice 100s: Trailblazers - 2 months ago What 3 layoff stories reveal about pharma’s troubles - 4 months ago Pharma’s ‘it’ therapy — a new drug class gaining steam - 4 months ago What pharma has learned from AI - 5 months ago Pharma’s R&D gamble: picking pipeline winners in a risky field - 7 months ago Where competition is heating up in pharma - 7 months ago The biggest questions hanging over pharma in 2024 - 11 months ago Pharma execs sound off on trends and policies they’re tracking in 2024 - 12 months ago PharmaVoice’s Crystal Ball: What’s next in drug innovation and clinical trials - 12 months ago PharmaVoice 100s: Entrepreneurs - about 1 year ago PharmaVoice 100s: Clinical trial gurus - about 1 year ago
3	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	Oncology, obesity and more: Where pharma R&D is headed in 2025 - 10 days ago From Mr. Mucus to the Super Bowl, pharma tries offbeat marketing strategies - about 1 month ago 2024 PharmaVoice 100s: Clinical Trial Pros - about 2 months ago 2024 PharmaVoice 100s: Tech and AI Wizards - about 2 months ago Can BioNTech sustain a post-COVID mRNA pipeline? Oncology is the next hope. - 4 months ago Behind the powerful computations, AI’s role in pharma is still beset by challenges - 7 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - 10 months ago Pharma CFOs need R&D vigilance in tough economic times - 10 months ago
4	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: Pharma still ‘falling short’ in providing access to low- and middle-income countries, analysis finds - about 1 month ago STAT+: Pharmalittle: We’re reading about GSK leaving BIO, an AbbVie schizophrenia drug failing, and more - about 1 month ago STAT+: Pharmalittle: We’re reading about pharma risks in China, mitigating shortages, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about Moderna R&D cuts, Lilly plant investments and more - 3 months ago STAT+: Major generic maker Aurobindo cuts production at a key plant amid concerns over shortages - 11 months ago STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more - 11 months ago STAT+: Pharmalittle: We’re reading about FDA’s syphillis-drug plan, India’s manufacturer-inspection demands, and more - 12 months ago STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds - about 1 year ago STAT+: FDA cites Dr. Reddy’s for quality control problems at a biologics plant - about 1 year ago STAT+: Pharmalittle: Novo Nordisk to spend $6 billion to boost production; FDA okays world’s first vaccine for chikungunya - about 1 year ago STAT+: Pharmalittle: Pharma moves closer to a pricing deal with U.K.; FDA to review AstraZeneca request for self-administered flu vax - about 1 year ago STAT+: Pharmalittle: Weight-loss drugs fuel boom for firms that fill syringes; employers that cover obesity drug may double in 2024 - about 1 year ago STAT+: Pharmalittle: FDA finds problems at Novo’s main U.S. factory; polarizing ALS drug heads for FDA scrutiny - over 1 year ago
5	Associated Press MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Nearly 2,000 Pharmaceutical Plants Are Overdue for FDA Checks After COVID Delays - 4 months ago
6	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Novartis to spend $200 million in further bid to boost radiopharma manufacturing, market dominance - 4 months ago
7	PharmaTimes PharmaTimes PharmaTimes Media Ltd. Digital health news. Surrey, United Kingdom pharmahealthdigital healthmhealthNHSmarketingcommunicationsclinicaljobsMSL	eXmoor pharma’s manufacturing facility receives licence from MHRA - 4 months ago 2024 - 11 months ago
8	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing	Kite’s next-gen CAR-T aims include quicker production and more disease targets - 10 months ago Pharma takes a gut check of microbiome drugs - 11 months ago What are pharma’s next blockbusters? - about 1 year ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - about 1 year ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - about 1 year ago
9	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Years and years - 11 months ago
10	Alexandra Pecci Pharma Voice Leading community for life sciences leaders. Washington, D.C. pharmaceuticalslife sciencescommunity building	5 noteworthy pharma AI investments in 2023 - about 1 year ago

Journalists covering pharma manufacturing